StockNews.AI
EHC
StockNews.AI
33 days

Kirby McInerney LLP Announces Investigation Against Encompass Health Corporation (EHC) on Behalf of Investors

1. Kirby McInerney LLP investigates potential securities law violations by Encompass Health. 2. The New York Times reported concerning safety issues at Encompass Health hospitals. 3. Federal data shows significant readmission rates and alarming medical errors. 4. Shares dropped by 10.4% on July 15, impacting investor confidence. 5. Investors may pursue claims for damages related to these issues.

3m saved
Insight
Article

FAQ

Why Very Bearish?

The significant drop in share price and ongoing legal investigation indicate severe loss of investor confidence, reminiscent of previous cases where safety violations led to stock declines in healthcare companies.

How important is it?

The potential legal ramifications and safety concerns can significantly influence investor sentiment and future performance for EHC.

Why Short Term?

The immediate nature of the investigation and the recent share price decline suggest swift market reactions, but the long-term impacts will depend on future developments.

Related Companies

HCAUHSCYH
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Encompass Health Corporation (“Encompass Health” or the “Company”) (NYSE:EHC). The investigation concerns whether Encompass Health and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] On July 15, 2025, The New York Times published an article highlighting safety concerns at several of Encompass Health’s rehabilitation hospitals. Specifically, the article revealed that federal data and inspection reports show that Encompass Health’s hospitals have “statistically significantly worse rates of potentially preventable readmissions.” The report further revealed “alarming mistakes” including carbon monoxide poisoning, medication errors, and bed alarm failures leading to fatalities of patients in their care. On this news, the price of Encompass Health’s shares declined by $12.39, or approximately 10.4%, to close at $107.28 per share on July 15, 2025, thereby injuring investors. If you purchased or otherwise acquired Encompass securities, have information, or would like to learn more about this investigation, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out the form below to discuss your rights or interests with respect to these matters without any cost to you. [CONTACT US] Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. ContactsKirby McInerney LLPThomas W. Elrod, Esq.212-699-1180https://www.kmllp.cominvestigations@kmllp.com

Related News